RRx-001
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for RRx-001, covering 2016-01-21 to 2025-03-17. Get the full timeline:
Most recent: Clinical Trial Update: RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) [Phase 2]